Latest Breaking News On - Arima genomics inc - Page 1 : comparemela.com

Aventa Genomics Announces Launch of Aventa FusionPlus

Aventa™ Genomics, LLC, a clinical laboratory established as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics Inc., today announced the launch of Aventa FusionPlus, a next-generation sequencing (NGS) test for the detection of gene fusions, translocations, and rearrangements across 361 genes from formalin-fixed, paraffin embedded (FFPE) tumor tissue.

United statesAventa fusionplusAventa genomicsoctArima genomics incProtean biodiagnostics incFrom aventa genomicsoctArima genomics

Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical advisory board to help the company advance its 3D genomics technologies into the clinical oncology and biopharmaceutical markets.

Anthony schmittMatija snuderlKen youngKenh youngDarren sigalArima genomics incLangone healthDuke universityHematopathology divisionProfessor of pathology at duke universityDuke blood cancer pathology programArima genomicsArima genomicSenior vice presidentProtean biodiagnosticsGabrielle raia

Follow the Money: Single-Cell Analysis, Spatial Biology, Drug-Resistant Infection Treatments, 3D Genomics

Follow the Money: Single-Cell Analysis, Spatial Biology, Drug-Resistant Infection Treatments, 3D Genomics
bio-itworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio-itworld.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPatrick heronJames topperMatt mcllwainTensixteen bioViva bioinnovatorRandy harrisonJohn doerrJeff deanJohn chambersSemarion semacyteLloyd payneMichael pelliniAndreessen horowitzDan estes

Active Motif Partners with Arima Genomics to Launch End-to-End Hi-C Service

Press release content from PR Newswire. The AP news staff was not involved in its creation. Active Motif Partners with Arima Genomics to Launch End-to-End Hi-C Service February 9, 2021 GMT SAN DIEGO and CARLSBAD, Calif., Feb. 9, 2021 /PRNewswire/ Epigenetics-based research tools and services company, Active Motif, Inc., announced today that it has launched an end-to-end Hi-C service in partnership with Arima Genomics, Inc. to investigate the three-dimensional folding patterns of the genome, providing researchers with greater access to this powerful technology and advancing their research. The launch of this Hi-C service extends Active Motif’s 15 years of experience and expertise offering Epigenetic Services, such as ChIP-Seq and ATAC-Seq services, and now allows researchers to gain a deeper understanding of the biological mechanisms at play in their clinical samples or experimental systems. Active Motif continues to offer the most comprehensive offering of epigenetic services

United statesSan diegoWellcome sanger insituteKevin bryantSiddarth selvarajFritz eibelEpigenetic servicesMotif incMotif epigenetic serviceArima genomics incActive motifArima genomicsActive motif epigenetic serviceChief commercial officerCorporate newsNorth america